Real time insider trading transaction history:

  • Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Insider Trading Transactions for KAKKIS EMIL D
Common stock purchase or sale:
Transaction
Date
Reported
DateTime
CompanySymbolInsider
Relationship
Shares
Traded
Average
Price
Total
Amount
Shares
Owned
Filing
2022-12-30
Sale
2023-01-03
4:45 pm
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
19,582$45.57$892,3522,824,385
(Indirect
Direct)
View
2021-05-03
Sale
2021-05-05
11:32 am
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
30,000$107.8$3,234,0002,855,793
(Indirect
Direct)
View
2021-03-01
Sale
2021-03-03
8:36 pm
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
30,000$141.8$4,254,0002,921,793
(Indirect
Direct)
View
2021-01-04
Sale
2021-01-05
6:45 pm
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
30,000$136.9$4,107,0002,939,930
(Indirect
Direct)
View
2020-11-02
Sale
2020-11-04
3:44 pm
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
30,000$96.82$2,904,6002,969,930
(Indirect
Direct)
View
2020-09-01
Sale
2020-09-02
4:26 pm
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
30,000$82.63$2,478,9003,000,782
(Indirect
Direct)
View
2020-07-13
Sale
2020-07-15
1:22 pm
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
40,000$85.35$3,414,0003,030,782
(Indirect
Direct)
View
2019-09-11
Purchase
2019-09-11
12:35 pm
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
5,000$43.63$218,1503,032,220
(Indirect
Direct)
View
2019-03-01
Sale(A)
2019-04-17
5:38 pm
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
2,890$65.52$189,3533,093,324
(Indirect
Direct)
View

Stock options: Exercise, Award, Grant, Conversion
Transaction
Date
Reported
DateTime
Exercisable
Expiration
CompanySymnbolInsider
Relationship
Shares
Traded
Conversion
Price
Shares
Owned
Filing
2022-03-01
Tax Withholding
2022-03-03
6:06 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
12,162$67.372,936,327
(Direct)
View
2022-03-01
Option Award
2022-03-03
6:06 pm
N/A
2032-03-01
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
144,401$02,936,327
(Direct)
View
2021-12-31
Ownership
2022-02-01
1:41 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
0$02,804,088
(Direct)
View
2021-12-31
Ownership
2022-02-01
1:41 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
50,000$02,804,088
(Indirect)
View
2021-10-14
Tax Withholding
2021-10-18
6:44 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
853$812,854,088
(Direct)
View
2021-05-06
Tax Withholding
2021-05-10
6:11 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
852$115.712,854,941
(Direct)
View
2021-03-01
Tax Withholding
2021-03-03
8:36 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
16,342$142.472,921,793
(Direct)
View
2021-03-01
Option Award
2021-03-03
8:36 pm
N/A
2031-03-01
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
69,453$02,921,793
(Direct)
View
2020-12-31
Ownership
2021-02-03
8:03 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
181,670$02,928,682
(Indirect)
View
2020-10-14
Tax Withholding
2020-10-16
7:23 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
852$92.692,999,930
(Direct)
View
2020-06-01
Tax Withholding
2020-06-03
2:17 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
1,334$69.383,070,782
(Direct)
View
2020-05-06
Tax Withholding
2020-05-08
8:06 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
852$66.263,212,538
(Direct)
View
2020-04-19
Tax Withholding
2020-04-21
3:34 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
851$58.573,213,390
(Direct)
View
2020-03-12
Exercise
2020-03-13
12:59 pm
2010-06-30
2020-06-30
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
149,700$03,214,241
(Direct)
View
2020-03-12
Exercise
2020-03-13
12:59 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
149,700$3.0063,214,241
(Direct)
View
2020-03-01
Option Award
2020-03-03
7:58 pm
N/A
2030-03-01
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
91,882$03,120,641
(Direct)
View
2020-03-01
Tax Withholding
2020-03-03
7:58 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
6,896$56.083,120,641
(Direct)
View
2019-10-14
Option Award
2019-10-16
7:30 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
3,435$03,035,655
(Direct)
View
2019-06-01
Tax Withholding
2019-06-04
6:59 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
1,327$54.933,027,220
(Direct)
View
2019-05-21
Tax Withholding
2019-05-22
5:44 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
1,414$59.53,028,547
(Direct)
View
2019-05-06
Option Award
2019-05-07
6:57 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
3,435$03,029,961
(Direct)
View
2019-04-19
Tax Withholding
2019-04-23
6:41 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
798$64.433,026,526
(Direct)
View
2019-03-01(A)
Option Award
2019-04-17
5:38 pm
N/A
2029-03-01
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
86,000$03,093,324
(Direct)
View
2019-03-01
Tax Withholding
2019-03-04
5:00 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
2,802$67.553,093,411
(Direct)
View
2019-03-01
Option Award
2019-03-04
5:00 pm
N/A
2029-03-01
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
86,000$03,093,411
(Direct)
View
2018-06-01
Tax Withholding
2018-06-04
4:45 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
926$73.733,010,213
(Direct)
View
2018-05-21
Tax Withholding
2018-05-22
11:42 am
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
986$64.793,011,139
(Direct)
View
2018-04-19
Option Award
2018-04-19
4:42 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
3,429$03,012,125
(Direct)
View
2018-03-01
Tax Withholding
2018-03-05
4:12 pm
N/A
N/A
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
1,114$48.433,103,196
(Direct)
View
2018-03-01
Option Award
2018-03-05
4:12 pm
N/A
2028-03-01
Ultragenyx Pharmaceutical Inc.RAREKAKKIS EMIL D
President & CEO
114,000$03,103,196
(Direct)
View
(A) Indicate amendment filing.